Login to Your Account



WARNING FOR BRANDED GENERICS

China's 'zero markup' hospital reforms mixed bag for patented drugs

By Shannon Ellis
Staff Writer

Wednesday, July 9, 2014

SHANGHAI – As part of health care reforms, China has been piloting "zero markups" for drugs sold at hospitals for several years in a bid to reduce and rationalize the cost of health care. According to the State Council work plan, this year will see a significant expansion of the pilot, with half of all county-level hospitals and one city per province expected to have adopted the new drug pricing policy by the end of the year.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription